ADMA Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	87.63	103.15	51.35	86.52	51.09
Cash & Short-Term Investments	87.63	103.15	51.35	86.52	51.09
Cash Growth	-15.04%	100.86%	-40.65%	69.36%	-8.64%
Accounts Receivable	158.43	50	27.42	15.51	28.58
Inventory	206.47	170.24	172.91	163.28	124.72
Other Current Assets	13.99	8.03	5.33	5.1	4.34
Total Current Assets	466.51	331.41	257.01	270.4	208.73
Net Property, Plant & Equipment	71.71	63.34	63.47	68.75	58.2
Other Intangible Assets	0.63	0.46	0.5	1.01	1.73
Goodwill	3.53	3.53	3.53	3.53	3.53
Other Long-Term Assets	81.86	89.94	4.67	4.77	4.07
Total Assets	624.24	488.68	329.18	348.46	276.25
Accounts Payable	22.52	20.22	15.66	13.23	12.43
Accrued Expenses	40.47	34.11	32.92	24.99	17.21
Current Portion of Long-Term Debt	2.81	-	-	-	-
Current Portion of Leases	1.1	1.22	1.05	0.91	0.59
Unearned Revenue	-	-	0.18	0.14	0.14
Other Current Liabilities	2.65	-	-	-	-
Total Current Liabilities	69.54	55.54	49.81	39.27	30.38
Long-Term Debt	69.33	73.65	132.28	144.33	94.87
Long-Term Leases	6.65	8.56	9.78	10.7	7.46
Other Long-Term Liabilities	1.41	1.91	2.11	2.18	2.37
Total Long-Term Liabilities	77.38	84.12	144.17	157.22	104.7
Total Liabilities	146.92	139.66	193.98	196.49	135.08
Common Stock	0.02	0.02	0.02	0.02	0.02
Treasury Stock	-32.09	-	-	-	-
Additional Paid-in Capital	671.04	657.58	641.44	629.97	553.27
Retained Earnings	-161.65	-308.58	-506.26	-478.02	-412.11
Shareholders' Equity	477.32	349.02	135.21	151.97	141.17
Total Liabilities & Equity	624.24	488.68	329.18	348.46	276.25
Total Debt	79.89	83.43	143.11	155.94	102.92
Net Cash (Debt)	7.75	19.72	-91.75	-69.42	-51.83
Net Cash Growth	-60.72%	-	-	-	-
Net Cash Per Share	0.03	0.08	-0.41	-0.35	-0.37
Book Value	477.32	349.02	135.21	151.97	141.17
Book Value Per Share	1.95	1.43	0.60	0.77	1.01
Tangible Book Value	473.16	345.03	131.18	147.43	135.91
Tangible Book Value Per Share	1.93	1.42	0.59	0.75	0.97

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q